4.6 Editorial Material

Th1 epitope selection for clinically effective cancer vaccines

期刊

ONCOIMMUNOLOGY
卷 3, 期 9, 页码 -

出版社

TAYLOR & FRANCIS INC
DOI: 10.4161/21624011.2014.954971

关键词

Th1; Th2; epitope; Helper T-cells; IGFBP-2

向作者/读者索取更多资源

New cancer immunotherapies mark progress in our understanding of tumor biology and harnessing the immune system's management of self. However, protein- and peptide- based vaccines are not yet consistently efficacious. Recent work uncovers principles governing the genesis of T helper type- restrictive immunity to self- antigens elicited by vaccine epitopes, enabling vaccines to skew the balance from tolerogenic Type II (Th2) to inflammatory Type I (Th1) T cells, and invigorating this cancer immunotherapeutic approach.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据